Publication: Magyar Közlöny
Issue: MK-2008-191 (Year: 2008, Number: 191)
Era: 2004-2010
Section: A Kormány a sportbeli dopping elleni nemzetközi egyezmény kihirdetésérõl szóló 99/2007. (V. 8.) Korm. rendelettel
Paragraph Index: 2520

1. Anabolic Androgenic Steroids (AAS) a. Exogenous* AAS, including: 1-androstendiol (5-androst-1-ene-3,17-diol); 1-androstendione (5-androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17-ethynyl-17-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17-hydroxy-17-methylandrosta- 1,4-dien-3-one); desoxymethyltestosterone (17-methyl-5-androst-2-en-17-ol); drostanolone; ethylestrenol (19-nor-17-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17-hydroxy-17-methyl-5-androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17-dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17-hydroxy-17-methylandrosta-1,4-dien-3-one); methandriol; methasterone (2, 17-dimethyl-5-androstane-3-one-17-ol); methyldienolone (17-hydroxy-17-methylestra-4,9-dien-3-one); methyl-1-testosterone (17-hydroxy-17-methyl-5-androst-1-en-3-one); methylnortestosterone (17-hydroxy-17-methylestr-4-en-3-one); methyltrienolone (17-hydroxy-17-methylestra-4,9,11-trien-3-one); methyltestosterone; mibolerone; nandrolone; 19-norandrostenedione (estr-4-ene-3,17-dione); norboletone; norclostebol; norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; prostanozol (17-hydroxy-5-androstano[3,2-c] pyrazole); quinbolone; stanozolol; stenbolone; 1-testosterone (17-hydroxy-5-androst- 1-en-3-one); tetrahydrogestrinone (18a-homo-pregna- 4,9,11-trien-17-ol-3-one); trenbolone and other substances with a similar chemical structure or similar biological effect(s). b. Endogenous** AAS when administered exogenously: androstenediol (androst-5-ene-3,17-diol); androstenedione (androst-4-ene-3,17-dione); dihydrotestosterone (17-hydroxy-5-androstan-3-one); prasterone (dehydroepiandrosterone, DHEA); testosterone and the following metabolites and isomers: 5-androstane-3,17-diol; 5-androstane-3,17-diol; 5-androstane-3,17-diol; 5-androstane-3,17-diol; androst-4-ene-3,17-diol; androst-4-ene-3,17-diol; androst-4-ene-3,17-diol; androst-5-ene-3,17-diol; androst-5-ene-3,17-diol; androst-5-ene-3,17-diol; 4-androstenediol (androst-4-ene-3,17-diol); 5-androstenedione (androst-5-ene-3,17-dione); epi-dihydrotestosterone; epitestosterone; 3-hydroxy-5-androstan-17-one; 3-hydroxy-5-androstan-17-one; 19-norandrosterone; 19-noretiocholanolone. [Comment to class S1.1b: Where an anabolic androgenic steroid is capable of being produced endogenously, a Sample will be deemed to contain such Prohibited Substance and an Adverse Analytical Finding will be reported where the 2005/191. szám concentration of such Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete¨s Sample so deviates from the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where an Athlete proves that the concentration of the Prohibited Substance or its metabolites or markers and/or the relevant ratio(s) in the Athlete’s Sample is attributable to a physiological or pathological condition. In all cases, and at any concentration, the Athlete¨s Sample will be deemed to contain a Prohibited Substance and the laboratory will report an Adverse Analytical Finding if, based on any reliable analytical method (e.g. IRMS), the laboratory can show that the Prohibited Substance is of exogenous origin. In such case, no further investigation is necessary. When a value does not so deviate from the range of values normally found in humans and any reliable analytical method (e.g. IRMS) has not determined the exogenous origin of the substance, but if there are indications, such as a comparison to endogenous reference steroid profiles, of a possible Use of a Prohibited Substance, or when a laboratory has reported a T/E ratio greater than four (4) to one (1) and any reliable analytical method (e.g. IRMS) has not determined the exogenous origin of the substance, further investigation shall be conducted by the relevant Anti-Doping Organization by reviewing the results of any previous test(s) or by conducting subsequent test(s). When such further investigation is required the result shall be reported by the laboratory as atypical and not as adverse. If a laboratory reports, using an additional reliable analytical method (e.g. IRMS), that the Prohibited Substance is of exogenous origin, no further investigation is necessary, and the Sample will be deemed to contain such Prohibited Substance. When an additional reliable analytical method (e.g. IRMS) has not been applied, and the minimum of three previous test results are not available, a longitudinal profile of the Athlete shall be established by performing three no-advance notice tests in a period of three months by the relevant Anti-Doping Organization. The result that triggered this longitudinal study shall be reported as atypical. If the longitudinal profile of the Athlete established by the subsequent tests is not physiologically normal, the result shall then be reported as an Adverse Analytical Finding. In extremely rare individual cases, boldenone of endogenous origin can be consistently found at very low nanograms per milliliter (ng/mL) levels in urine. When such a very low concentration of boldenone is reported by a laboratory and the application of any reliable analytical method (e.g. IRMS) has not determined the exogenous origin of the substance, further investigation may be conducted by subsequent test(s). For 19-norandrosterone, an Adverse Analytical Finding reported by a laboratory is considered to be scientific and valid proof of exogenous origin of the Prohibited Substance. In such case, no further investigation is necessary. Should an Athlete fail to cooperate in the investigations, the Athlete’s Sample shall be deemed to contain a Prohibited Substance.]

Source: https://magyarkozlony.hu/hivatalos-lapok/c4b56efe351ebcc60436c721a22ba7983ed6e587/dokumentumok/ffb6b9d278aaccc28f33d4c4ae8c451b158abf8a/letoltes